Biotech Co. Says Red Cross Plainly Violated Antitrust Law
A biotech company defended its suit in Massachusetts federal court accusing the American National Red Cross of snuffing out competition in the platelet bacteria mitigation market, contending the case is straightforward...To view the full article, register now.
Already a subscriber? Click here to view full article